ADPT vs CLOV
Adaptive Biotechnologies Corp (ADPT) versus Clover Health Investments Corp (CLOV) — a side-by-side from cached financials, not a winner call.
Adaptive Biotechnologies Corp (ADPT) is a diagnostics & research company listed on NASDAQ.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Latest reported ADPT revenue for 2024-12-31 was $179.0M. Net income was -$159.6M. Revenue was up 5.1% from 2023-12-31 to 2024-12-31. ADPT currently screens at market cap $2.69B.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
ADPT currently screens at market cap $2.69B. CLOV currently screens at market cap $1.55B.
Not investment advice. Open the ADPT and CLOV stock pages for the full models.
Not investment advice.